EUVIMEDEUVIMED entdecken
Crossref

Transformable Renal Cancer Targeted Responsive Nanopeptide Probes Effectively Inhibit Renal Cancer Progression and Metastasis by Inhibiting Renal Blood Vessels and Cancer Cells

Bin Kong, Xiuhai Wu, Cong Li, Pan Liu, Meiqun Chen, Yuwen Liu, Cunyao Liu, Xinyue Wang, Bogong Chen, Jiahui Zang, Lingrui Jian, Jiachen Shen und 6 weitere

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c16546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Bin Kong und 17 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, China. Hauptthemen laut MEDLINE: Kidney Neoplasms, Neovascularization, Pathologic, Carcinoma, Renal Cell, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsNeovascularization, PathologicCarcinoma, Renal CellPeptidesAntineoplastic AgentsAngiogenesis InhibitorsNanofibersHumansAnimalsMiceCell Line, TumorVascular Endothelial Growth Factor AApoptosisMice, NudeDisease ProgressionMice, Inbred BALB CCell Proliferation

Stichwörter der Autor:innen

TIE-2VEGFangiogenesisrenal cancerself-assembly

Substanzen

PeptidesVascular Endothelial Growth Factor AAntineoplastic AgentsAngiogenesis Inhibitors

Autor:innen und Institutionen

  • The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, China.
  • Biochemistry and Molecular Biology Department, Mayo Clinic, Rochester, Minnesota 55905, United States.
  • NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University, Harbin 150001, China.
  • Department of Urology, Harbin Medical University Cancer Hospital, Harbin 150001, China.
  • Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

ORCID-Profile: Lu Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Kong, B., Wu, X., Li, C., Liu, P., Chen, M., Liu, Y., Liu, C., Wang, X., Chen, B., Zang, J., Jian, L., Shen, J., Yu, J., Wu, Q., Yang, G., Wang, Z., Liu, M., & Wang, L. (2025). Transformable Renal Cancer Targeted Responsive Nanopeptide Probes Effectively Inhibit Renal Cancer Progression and Metastasis by Inhibiting Renal Blood Vessels and Cancer Cells. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c16546

Vancouver

Kong B, Wu X, Li C, Liu P, Chen M, Liu Y, et al. Transformable Renal Cancer Targeted Responsive Nanopeptide Probes Effectively Inhibit Renal Cancer Progression and Metastasis by Inhibiting Renal Blood Vessels and Cancer Cells. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c16546

BibTeX
@article{Kong2025,
  author = {Kong, Bin and Wu, Xiuhai and Li, Cong and Liu, Pan and Chen, Meiqun and Liu, Yuwen and Liu, Cunyao and Wang, Xinyue and Chen, Bogong and Zang, Jiahui and Jian, Lingrui and Shen, Jiachen and Yu, Jiaao and Wu, Qiang and Yang, Guang and Wang, Ziqi and Liu, Ming and Wang, Lu},
  title = {Transformable Renal Cancer Targeted Responsive Nanopeptide Probes Effectively Inhibit Renal Cancer Progression and Metastasis by Inhibiting Renal Blood Vessels and Cancer Cells},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c16546}
}
Kostenlos starten →